Trial Profile
An Expanded IND Access Investigation of HBOC-201 Infusion in Patients With Severe Acute Anemia Who Are Unable to Receive Red Blood Cell Transfusion
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Hemoglobin glutamer (Primary)
- Indications Anaemia
- Focus Expanded access; Therapeutic Use
- 23 Aug 2018 New trial record